Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05233033
Title Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients With Relapsed or Refractory B-cell NHL
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kymera Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Virginia Comprehensive Cancer Center Charlottesville Virginia 22903 United States Details
University College London Hospitals London United Kingdom Details
University Hospital Southampton NHS Foundation Trust Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field